科学护肝消费洞察报告：2024年护肝药品类销售额增速达26%

Core Insights - JD Health hosted the first "Scientific Liver Protection, Healthy Future" industry forum, releasing the "2025 Scientific Liver Protection Consumer Insight Report" in collaboration with Zhongkang Technology [1] Market Trends - The report indicates that liver protection drugs are characterized by high average transaction value and high repurchase frequency, driving continuous market expansion [1] - JD Health's data shows that the sales growth rate of liver protection drugs is expected to reach 26% year-on-year in 2024 [1] Consumer Behavior - Patients spend an average of over 1800 yuan annually on liver protection drugs, with an average transaction value exceeding 260 yuan [1] - The repurchase rate for these drugs is over 50%, with an average of nearly 7 repurchases per year per patient [1] Online Consultation Growth - JD Internet Hospital reports a significant increase in online consultations for liver diseases, with a growth rate exceeding 67% from Q2 2024 to Q2 2025 [1] Strategic Goals - JD Health aims to leverage its platform capabilities and resources to focus on early screening, prevention, and treatment of liver diseases, collaborating with partners to build a more comprehensive disease prevention and patient service system [1]